We seek those innovations that have a truly differentiated scientific basis, supported by convincing experimental data. These innovations must be compelling and stand out in the global scientific arena.
Only innovations that can address an unmet medical need in a significant way are being considered for investment. We aspire to invest in solutions that provide substantial healthcare impact.
Progressing a project from discovery to clinical proof-of-concept requires a breadth of experience that founding teams usually do not have from the outset. Through our extensive network and experience we help founders build their companies.
We guide our investees along their journey from the scientific discovery to a targeted product development track. Together with the founders we shape the company and define the objectives to enable a successful exit.